How to Treat Urinary Tract Infections (UTI): GSK's Gepotidacin May Work - Bloomberg
Antibiotics | Free Full-Text | Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges
gepotidacin - Drug Hunter
Overview of microbiome dynamics during gepotidacin Phase 2a clinical... | Download Scientific Diagram
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Safety Trial of New Antibiotic - YouTube
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants | SpringerLink
Antibiotics | Free Full-Text | Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose- Ranging, Single-Oral Dose Eva
Gepotidacin: New antibiotic appears to be effective against UTIs, company says | CNN
New Urinary Tract Infections Clinical Trial: Gepotidacin for Urinary Tract Infections - YouTube
GSK initiates Phase III programme of gepotidacin antibiotic
TITLE PAGE
Dose Selection for Phase 3 Studies Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | GSK
TITLE PAGE
Novel drug gepotidacin for uncomplicated UTI meets trial goals
Intracellular concentration-response curves of gepotidacin (GEP)... | Download Scientific Diagram
GSK stops two Phase 3 studies for gepotidacin stopped early
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose- Ranging, Single-Oral Dose Eva
Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections | Antimicrobial Agents and Chemotherapy
Gepotidacin for Urinary Tract Infection Clinical Trial 2023 | Power
